Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Raw Materials (2017 - 2025)

Dexcom (DXCM) has disclosed Raw Materials for 12 consecutive years, with $257.6 million as the latest value for Q4 2025.

  • Quarterly Raw Materials fell 21.25% to $257.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $257.6 million through Dec 2025, down 21.25% year-over-year, with the annual reading at $257.6 million for FY2025, 21.25% down from the prior year.
  • Raw Materials for Q4 2025 was $257.6 million at Dexcom, down from $266.0 million in the prior quarter.
  • The five-year high for Raw Materials was $366.0 million in Q1 2025, with the low at $87.5 million in Q1 2021.
  • Average Raw Materials over 5 years is $226.9 million, with a median of $244.4 million recorded in 2023.
  • The sharpest move saw Raw Materials surged 107.73% in 2021, then dropped 21.25% in 2025.
  • Over 5 years, Raw Materials stood at $145.2 million in 2021, then rose by 9.5% to $159.0 million in 2022, then surged by 100.94% to $319.5 million in 2023, then rose by 2.38% to $327.1 million in 2024, then decreased by 21.25% to $257.6 million in 2025.
  • According to Business Quant data, Raw Materials over the past three periods came in at $257.6 million, $266.0 million, and $346.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.